Description

Lanraplenib (Succinate) is a high-purity, small molecule active pharmaceutical ingredient (API) designed for advanced pharmaceutical research and development. This compound is a succinate salt form of Lanraplenib, offering enhanced stability and solubility for formulation studies. It is primarily utilized by pharmaceutical companies and research institutions engaged in the discovery and development of novel therapeutic agents, particularly in oncology and immunology. Our product is supplied with full traceability and comprehensive analytical documentation to support critical preclinical and clinical-stage work.

Application

• Pharmaceutical API Intermediate: Serves as a critical building block in the synthesis of final drug formulations.
• Oncology Research: Used in biochemical and cellular assays to study targeted cancer therapies.
• Preclinical Development: Employed in pharmacokinetic (PK), pharmacodynamic (PD), and toxicology studies.
• Formulation Development: The succinate salt form is ideal for optimizing drug solubility and stability in various dosage forms.
• Reference Standard: Acts as a high-purity analytical standard for quality control and method validation in laboratories.
• Drug Discovery Screening: Utilized in high-throughput screening (HTS) campaigns to identify and validate new drug candidates.

Basic Information

Product Name	Lanraplenib (Succinate)
CAS No.	1800047-00-0
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	GS-9876 Succinate; SYK Inhibitor GS-9876 Succinate; Lanraplenib succinate salt; (S)-2-((1-(1H-Pyrazolo[3,4-c]pyridin-6-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)amino)-2-(4-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)piperidin-1-yl)acetic acid succinate; Entospletinib analog succinate
EINECS	Contact for details

Quality Control

Our Lanraplenib (Succinate) is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, residual solvent analysis, and identification by spectroscopic methods, to ensure it meets the stringent requirements for pharmaceutical research. A Certificate of Analysis (COA) detailing all test results and specifications is provided with every shipment to guarantee traceability and compliance with your project needs.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as indicated on the label. The product is hygroscopic (moisture-sensitive) and must be kept in a dry environment. For long-term storage, consider desiccants or inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC/IR)	Conforms to reference standard
Assay (HPLC)	≥98.0%
Related Substances (HPLC)	Total impurities ≤2.0%
Water Content (KF)	≤1.0%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.